Clinical Trials
4 trialsNCT07621159 2026-06-02
A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
NCT05759728 2026-01-13
A Study of CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Administered to Subjects With Metastatic Colorectal Cancer
Carina Biotech Limited
Phase 1/2 Recruiting
NCT06008119 2025-09-18
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Shanghai Kechow Pharma, Inc.
Phase 3 Recruiting
NCT05589597 2025-08-22
AUDREY
Enterome
Phase 1/2 Terminated